PDB Short entry for 5EI6 HEADER TRANSFERASE 29-OCT-15 5EI6 TITLE RAPID DISCOVERY OF PYRIDO[3,4-D]PYRIMIDINE INHIBITORS OF MONOPOLAR TITLE 2 SPINDLE KINASE 1 (MPS1) USING A STRUCTURE-BASED HYDRIDIZATION TITLE 3 APPROACH COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE,PYT; COMPND 5 EC: 2.7.12.1; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: N-(2,4-DIMETHOXYPHENYL)-5-(1-METHYL-1H-PYRAZOL-4-YL) COMPND 8 ISOQUINOLIN-3-AMINE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTK, MPS1, MPS1L1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693 KEYWDS SPINDLE ASSEMBLY CHECKPOINT (SAC), ONCOLOGY TARGET PYRIDO[3, 4- KEYWDS 2 D]PYRIMIDINE BASED INHIBITORS SELECTIVE AGAINST MPS1, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.INNOCENTI,H.L.WOODWARD,S.SOLANKI,N.NAUD,I.M.WESTWOOD,N.CRONIN, AUTHOR 2 A.HAYES,J.ROBERTS,A.T.HENLEY,R.BAKER,A.FAISAL,G.MAK,G.BOX,M.VALENTI, AUTHOR 3 A.DE HAVEN BRANDON,L.O'FEE,J.SAVILLE,J.SCHMITT,R.BURKE,R.L.M.VAN AUTHOR 4 MONTFORT,F.I.RAYMAUD,S.A.ECCLES,S.LINARDOPOULOS,J.BLAGG,S.HOELDER REVDAT 3 30-AUG-17 5EI6 1 REMARK REVDAT 2 11-MAY-16 5EI6 1 JRNL REVDAT 1 20-APR-16 5EI6 0 JRNL AUTH P.INNOCENTI,H.L.WOODWARD,S.SOLANKI,S.NAUD,I.M.WESTWOOD, JRNL AUTH 2 N.CRONIN,A.HAYES,J.ROBERTS,A.T.HENLEY,R.BAKER,A.FAISAL, JRNL AUTH 3 G.W.MAK,G.BOX,M.VALENTI,A.DE HAVEN BRANDON,L.O'FEE, JRNL AUTH 4 H.SAVILLE,J.SCHMITT,B.MATIJSSEN,R.BURKE,R.L.VAN MONTFORT, JRNL AUTH 5 F.I.RAYNAUD,S.A.ECCLES,S.LINARDOPOULOS,J.BLAGG,S.HOELDER JRNL TITL RAPID DISCOVERY OF PYRIDO[3,4-D]PYRIMIDINE INHIBITORS OF JRNL TITL 2 MONOPOLAR SPINDLE KINASE 1 (MPS1) USING A STRUCTURE-BASED JRNL TITL 3 HYBRIDIZATION APPROACH. JRNL REF J.MED.CHEM. V. 59 3671 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27055065 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01811 REMARK 2 REMARK 2 RESOLUTION. 2.01 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.01 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 28997 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.890 REMARK 3 FREE R VALUE TEST SET COUNT : 1419 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.97 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.04 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2814 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2021 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2689 REMARK 3 BIN R VALUE (WORKING SET) : 0.2018 REMARK 3 BIN FREE R VALUE : 0.2085 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.44 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 125 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2047 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.26 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.36450 REMARK 3 B22 (A**2) : -6.44570 REMARK 3 B33 (A**2) : 1.08120 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.286 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.126 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.117 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.126 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.118 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.954 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2127 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2886 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 710 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 49 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 330 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2127 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 288 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2433 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.03 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.96 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.74 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|516 - 620} REMARK 3 ORIGIN FOR THE GROUP (A): 6.0405 21.1711 -13.6047 REMARK 3 T TENSOR REMARK 3 T11: -0.0893 T22: -0.0414 REMARK 3 T33: -0.0705 T12: -0.0169 REMARK 3 T13: 0.0435 T23: 0.0641 REMARK 3 L TENSOR REMARK 3 L11: 4.9359 L22: 1.0166 REMARK 3 L33: 2.9280 L12: 1.4862 REMARK 3 L13: 0.2259 L23: -1.0390 REMARK 3 S TENSOR REMARK 3 S11: -0.0701 S12: -0.3107 S13: -0.3172 REMARK 3 S21: 0.1427 S22: 0.0467 S23: -0.1490 REMARK 3 S31: -0.1207 S32: -0.0331 S33: 0.0234 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {A|621 - 794} REMARK 3 ORIGIN FOR THE GROUP (A): -10.8881 10.9680 -27.2886 REMARK 3 T TENSOR REMARK 3 T11: -0.1599 T22: -0.0611 REMARK 3 T33: -0.0301 T12: 0.0051 REMARK 3 T13: -0.0216 T23: 0.0885 REMARK 3 L TENSOR REMARK 3 L11: 3.1751 L22: 1.9291 REMARK 3 L33: 3.0493 L12: -0.6156 REMARK 3 L13: 0.4066 L23: -0.7199 REMARK 3 S TENSOR REMARK 3 S11: 0.0878 S12: -0.0752 S13: -0.4775 REMARK 3 S21: -0.1652 S22: -0.0875 S23: 0.3024 REMARK 3 S31: 0.3264 S32: -0.0928 S33: -0.0003 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5EI6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000214956. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-X REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29341 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.010 REMARK 200 RESOLUTION RANGE LOW (A) : 40.170 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 20.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PROPANE, 0.2 M MGCL2, REMARK 280 0.2 M SODIUM FORMATE, 20% PEG 3350, PH 7.5, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 34.98000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 52.02200 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 55.63950 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 34.98000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 52.02200 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 55.63950 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 34.98000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 52.02200 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 55.63950 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 34.98000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 52.02200 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 55.63950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 496 REMARK 465 HIS A 497 REMARK 465 HIS A 498 REMARK 465 HIS A 499 REMARK 465 HIS A 500 REMARK 465 HIS A 501 REMARK 465 HIS A 502 REMARK 465 SER A 503 REMARK 465 SER A 504 REMARK 465 GLY A 505 REMARK 465 VAL A 506 REMARK 465 ASP A 507 REMARK 465 LEU A 508 REMARK 465 GLY A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 ASN A 512 REMARK 465 LEU A 513 REMARK 465 TYR A 514 REMARK 465 PHE A 515 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 THR A 795 REMARK 465 HIS A 796 REMARK 465 PRO A 797 REMARK 465 VAL A 798 REMARK 465 ASN A 799 REMARK 465 GLN A 800 REMARK 465 MET A 801 REMARK 465 ALA A 802 REMARK 465 LYS A 803 REMARK 465 GLY A 804 REMARK 465 THR A 805 REMARK 465 THR A 806 REMARK 465 GLU A 807 REMARK 465 GLU A 808 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 516 CG CD OE1 NE2 REMARK 470 LYS A 538 NZ REMARK 470 GLU A 545 CG CD OE1 OE2 REMARK 470 LYS A 546 CG CD CE NZ REMARK 470 LYS A 547 NZ REMARK 470 GLU A 559 CG CD OE1 OE2 REMARK 470 GLN A 563 CG CD OE1 NE2 REMARK 470 LYS A 577 CE NZ REMARK 470 GLN A 596 CD OE1 NE2 REMARK 470 LYS A 615 CE NZ REMARK 470 LYS A 616 CE NZ REMARK 470 LYS A 617 CG CD CE NZ REMARK 470 SER A 618 OG REMARK 470 TRP A 622 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 622 CZ3 CH2 REMARK 470 LYS A 629 CG CD CE NZ REMARK 470 GLU A 633 CG CD OE1 OE2 REMARK 470 LYS A 649 CE NZ REMARK 470 ASP A 657 CG OD1 OD2 REMARK 470 ASN A 669 CG OD1 ND2 REMARK 470 GLN A 670 CG CD OE1 NE2 REMARK 470 GLN A 672 CG CD OE1 NE2 REMARK 470 LYS A 680 CG CD CE NZ REMARK 470 VAL A 684 CG1 CG2 REMARK 470 ASP A 697 CG OD1 OD2 REMARK 470 SER A 709 OG REMARK 470 LYS A 710 CG CD CE NZ REMARK 470 ILE A 738 CG1 CG2 CD1 REMARK 470 GLU A 753 CG CD OE1 OE2 REMARK 470 GLU A 755 CG CD OE1 OE2 REMARK 470 ASP A 758 CG OD1 OD2 REMARK 470 LYS A 762 CD CE NZ REMARK 470 LYS A 777 CD CE NZ REMARK 470 GLN A 794 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 646 -0.42 69.88 REMARK 500 ASP A 657 70.61 37.00 REMARK 500 ALA A 668 -164.96 -120.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5OQ A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 903 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5EH0 RELATED DB: PDB REMARK 900 5EH0 CONTAINS THE SAME PROTEIN COMPLEXED WITH N2-(2-METHOXY-4-(1- REMARK 900 METHYL-1H-PYRAZOL-4-YL)PHENYL)-N8-NEOPENTYLPYRIDO[3,4-D]PYRIMIDINE- REMARK 900 2,8-DIAMINE DBREF 5EI6 A 519 808 UNP P33981 TTK_HUMAN 519 808 SEQADV 5EI6 MET A 496 UNP P33981 INITIATING METHIONINE SEQADV 5EI6 HIS A 497 UNP P33981 EXPRESSION TAG SEQADV 5EI6 HIS A 498 UNP P33981 EXPRESSION TAG SEQADV 5EI6 HIS A 499 UNP P33981 EXPRESSION TAG SEQADV 5EI6 HIS A 500 UNP P33981 EXPRESSION TAG SEQADV 5EI6 HIS A 501 UNP P33981 EXPRESSION TAG SEQADV 5EI6 HIS A 502 UNP P33981 EXPRESSION TAG SEQADV 5EI6 SER A 503 UNP P33981 EXPRESSION TAG SEQADV 5EI6 SER A 504 UNP P33981 EXPRESSION TAG SEQADV 5EI6 GLY A 505 UNP P33981 EXPRESSION TAG SEQADV 5EI6 VAL A 506 UNP P33981 EXPRESSION TAG SEQADV 5EI6 ASP A 507 UNP P33981 EXPRESSION TAG SEQADV 5EI6 LEU A 508 UNP P33981 EXPRESSION TAG SEQADV 5EI6 GLY A 509 UNP P33981 EXPRESSION TAG SEQADV 5EI6 THR A 510 UNP P33981 EXPRESSION TAG SEQADV 5EI6 GLU A 511 UNP P33981 EXPRESSION TAG SEQADV 5EI6 ASN A 512 UNP P33981 EXPRESSION TAG SEQADV 5EI6 LEU A 513 UNP P33981 EXPRESSION TAG SEQADV 5EI6 TYR A 514 UNP P33981 EXPRESSION TAG SEQADV 5EI6 PHE A 515 UNP P33981 EXPRESSION TAG SEQADV 5EI6 GLN A 516 UNP P33981 EXPRESSION TAG SEQADV 5EI6 SER A 517 UNP P33981 EXPRESSION TAG SEQADV 5EI6 MET A 518 UNP P33981 EXPRESSION TAG SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 313 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER VAL LYS SEQRES 3 A 313 GLY ARG ILE TYR SER ILE LEU LYS GLN ILE GLY SER GLY SEQRES 4 A 313 GLY SER SER LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS SEQRES 5 A 313 GLN ILE TYR ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA SEQRES 6 A 313 ASP ASN GLN THR LEU ASP SER TYR ARG ASN GLU ILE ALA SEQRES 7 A 313 TYR LEU ASN LYS LEU GLN GLN HIS SER ASP LYS ILE ILE SEQRES 8 A 313 ARG LEU TYR ASP TYR GLU ILE THR ASP GLN TYR ILE TYR SEQRES 9 A 313 MET VAL MET GLU CYS GLY ASN ILE ASP LEU ASN SER TRP SEQRES 10 A 313 LEU LYS LYS LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SEQRES 11 A 313 SER TYR TRP LYS ASN MET LEU GLU ALA VAL HIS THR ILE SEQRES 12 A 313 HIS GLN HIS GLY ILE VAL HIS SER ASP LEU LYS PRO ALA SEQRES 13 A 313 ASN PHE LEU ILE VAL ASP GLY MET LEU LYS LEU ILE ASP SEQRES 14 A 313 PHE GLY ILE ALA ASN GLN MET GLN PRO ASP THR THR SER SEQRES 15 A 313 VAL VAL LYS ASP SER GLN VAL GLY THR VAL ASN TYR MET SEQRES 16 A 313 PRO PRO GLU ALA ILE LYS ASP MET SER SER SER ARG GLU SEQRES 17 A 313 ASN GLY LYS SER LYS SER LYS ILE SER PRO LYS SER ASP SEQRES 18 A 313 VAL TRP SER LEU GLY CYS ILE LEU TYR TYR MET THR TYR SEQRES 19 A 313 GLY LYS THR PRO PHE GLN GLN ILE ILE ASN GLN ILE SER SEQRES 20 A 313 LYS LEU HIS ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU SEQRES 21 A 313 PHE PRO ASP ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU SEQRES 22 A 313 LYS CYS CYS LEU LYS ARG ASP PRO LYS GLN ARG ILE SER SEQRES 23 A 313 ILE PRO GLU LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN SEQRES 24 A 313 THR HIS PRO VAL ASN GLN MET ALA LYS GLY THR THR GLU SEQRES 25 A 313 GLU HET 5OQ A 901 27 HET DMS A 902 4 HET DMS A 903 4 HETNAM 5OQ ~{N}-(2,4-DIMETHOXYPHENYL)-5-(1-METHYLPYRAZOL-4-YL) HETNAM 2 5OQ ISOQUINOLIN-3-AMINE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 5OQ C21 H20 N4 O2 FORMUL 3 DMS 2(C2 H6 O S) FORMUL 5 HOH *72(H2 O) HELIX 1 AA1 ASP A 561 GLN A 579 1 19 HELIX 2 AA2 LEU A 609 LYS A 616 1 8 HELIX 3 AA3 ASP A 620 HIS A 641 1 22 HELIX 4 AA4 LYS A 649 ALA A 651 5 3 HELIX 5 AA5 PRO A 691 ASP A 697 1 7 HELIX 6 AA6 SER A 712 GLY A 730 1 19 HELIX 7 AA7 ASN A 739 ASP A 749 1 11 HELIX 8 AA8 GLU A 761 LEU A 772 1 12 HELIX 9 AA9 SER A 781 ALA A 787 1 7 HELIX 10 AB1 HIS A 788 ILE A 793 1 6 SHEET 1 AA1 6 SER A 517 VAL A 520 0 SHEET 2 AA1 6 ARG A 523 GLY A 534 -1 O ARG A 523 N VAL A 520 SHEET 3 AA1 6 SER A 537 LEU A 543 -1 O GLN A 541 N LYS A 529 SHEET 4 AA1 6 ILE A 549 ASN A 556 -1 O TYR A 550 N VAL A 542 SHEET 5 AA1 6 TYR A 597 MET A 602 -1 O MET A 602 N ALA A 551 SHEET 6 AA1 6 LEU A 588 ILE A 593 -1 N GLU A 592 O TYR A 599 SHEET 1 AA2 3 SER A 517 VAL A 520 0 SHEET 2 AA2 3 ARG A 523 GLY A 534 -1 O ARG A 523 N VAL A 520 SHEET 3 AA2 3 GLN A 672 PRO A 673 -1 O GLN A 672 N SER A 533 SHEET 1 AA3 3 ILE A 607 ASP A 608 0 SHEET 2 AA3 3 PHE A 653 VAL A 656 -1 O ILE A 655 N ILE A 607 SHEET 3 AA3 3 MET A 659 LEU A 662 -1 O MET A 659 N VAL A 656 SITE 1 AC1 13 ILE A 531 GLN A 541 ALA A 551 ILE A 586 SITE 2 AC1 13 GLU A 603 GLY A 605 ASN A 606 ASP A 608 SITE 3 AC1 13 SER A 611 LEU A 654 ILE A 663 MET A 671 SITE 4 AC1 13 PRO A 673 SITE 1 AC2 3 TYR A 525 TYR A 550 ASP A 590 SITE 1 AC3 1 TYR A 599 CRYST1 69.960 104.044 111.279 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014294 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009611 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008986 0.00000